|
Evaxion A/S
(NASDAQ: EVAX)
|
9:00 PM UTC, 12/12/25 | |||
|---|---|---|---|---|
| Last: $6.21 | Change: -0.24 | %Change: -3.72% | Volume: 70,895 | |
11:09 AM EST, 02/10/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts opened the week tracking higher late Monday morning, rising 0.55% to 1,386.89 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by accommodations booking company trivago (TRVG) and internet browser company Opera (OPRA), which rose 5.1% and 4.6%, respectively. They were followed by medical device maker EDAP TMS (EDAP) and petroleum refiner Equinor (EQNR), which increased 3.6% and 2.6%, respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and semiconductor company Sequans Communications (SQNS), which fell 8.5% and 3.2%, respectively. They were followed by furniture maker Natuzzi (NTZ) and biopharmaceutical company DBV Technologies (DBVT), which were down 2.8% and 1.9%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and oil and gas company BP (BP), which were up 74% and 6.6%, respectively. They were followed by financial services company HSBC (HSBC) and pharmaceutical company AstraZeneca (AZN), which were up 2% and 1.8%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm (TCBP) and Akari Therapeutics (AKTX), dropped 5.7% and 5%, respectively. They were followed by biotech firms Autolus Therapeutics (AUTL) and Trinity Biotech (TRIB), which lost 3.9% and 1.9%, respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.